Back to search

Belgium· BE-AMP-SAM170834-00

Nutrineal Peritoneal Dialysis 4 à 1,1 % d'Acides Aminés

A hypertonic solutions product containing tyrosine, registered in Belgium by Vantive Belgium. The same ATC class is registered in 11 of our 19 countries.

ATC B05DB

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedNutrineal Peritoneal Dialysis 4 à 1,1…ATCB05DBREGISTER NO.BE-AMP-SAM170834-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Tyrosine is registered in 11 of 19 countries.

Countries holding a registration under ATC B05DB (hypertonic solutions), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Tyrosine · ATC B05DB

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Tyrosine
Manufacturer
Vantive Belgium
Country
Belgium (BE)
ATC code
B05DB
ATC class
Hypertonic solutions
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    3932316
  • be_apb
    3932308

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tyrosine in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tyrosine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ecda739e-fd29-4953-ba40-d06bcd4984cb
GET /v1/drugs/ecda739e-fd29-4953-ba40-d06bcd4984cb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for peritoneal dialysis",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Nutrineal Peritoneal Dialysis 4 à 1,1 % d'Acides Aminés",
  "name_fr": "Nutrineal Peritoneal Dialysis 4 à 1,1 % d'Acides Aminés",
  "name_nl": "Nutrineal Peritoneal Dialysis 4 à 1,1 % d'Acides Aminés",
  "amp_code": "SAM170834-00",
  "strengths": [
    "0.3000",
    "0.3000",
    "1.3900",
    "1.3900",
    "0.5100",
    "0.5700",
    "4.4800",
    "0.9100",
    "1.0700",
    "1.0200",
    "0.0500",
    "0.8500"
  ],
  "pack_count": 10,
  "substances": [
    "Tyrosine",
    "Valine",
    "Glycine",
    "Phenylalanine",
    "Sodium Lactate",
    "Alanine",
    "Arginine",
    "Leucine",
    "Magnesium Chloride Hexahydrate",
    "Isoleucine",
    "Serine",
    "Histidine",
    "Threonine",
    "Proline",
    "Sodium Chloride",
    "Methionine",
    "Calcium Chloride Dihydrate",
    "Tryptophan",
    "Lysine"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Hypertonic Solutions",
  "authorisation_numbers": [
    "BE170834",
    "BE170843",
    "BE170852",
    "BE170861",
    "BE171193",
    "BE171202"
  ]
}

See everything about tyrosine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.